1,182
Views
39
CrossRef citations to date
0
Altmetric
Clinical Research

Characteristics and circumstances of synthetic cannabinoid-related death

, , , &
Pages 368-374 | Received 03 Jun 2019, Accepted 18 Jul 2019, Published online: 07 Aug 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Ferhat Turgut Tunçez, Kerem Sehlikoğlu, Umut Erdar Bilgin & Mehmet Tokdemir. (2023) Evaluation of forensic autopsy cases with substance use detected in Izmir, Turkey. Journal of Ethnicity in Substance Abuse 22:4, pages 688-700.
Read now
Ruben Goncalves, Magali Labadie, Simon Chouraqui, Alexandre Peyré, Nadège Castaing, Amélie Daveluy & Mathieu Molimard. (2022) Involuntary MDMB-4en-PINACA intoxications following cannabis consumption: clinical and analytical findings. Clinical Toxicology 60:4, pages 458-463.
Read now

Articles from other publishers (37)

Soheir Ali Mohammad, Rasha Elhaddad Ali Mousa, Sahar Mohamed Gebril, Khaled Masoud Mohamed Masoud & Rania Ahmad Radwan. (2023) Toxic effects of AB-CHMINACA on liver and kidney and detection of its blood level in adult male mice. Forensic Toxicology.
Crossref
Gábor Simon, Mónika Kuzma, Mátyás Mayer, Karola Petrus & Dénes Tóth. (2023) Fatal Overdose with the Cannabinoid Receptor Agonists MDMB-4en-PINACA and 4F-ABUTINACA: A Case Report and Review of the Literature. Toxics 11:8, pages 673.
Crossref
Gábor Kovács, Péter Gergely, Sándor Kosztya, Zsolt Kozma, Gábor Simon, György Szabados, Réka Anita Tóth, Klára Törő & Roland Weiczner. (2023) Módszertani ajánlás A járművezetés bódult állapotban bűncselekmény orvosszakértői véleményezésének egyes kérdéseiről. Belügyi Szemle 71:7, pages 1141-1168.
Crossref
Gábor Kovács, Péter Gergely, Sándor Kosztya, Zsolt Kozma, Gábor Simon, György Szabados, Réka Anita Tóth, Klára Törő & Roland Weiczner. (2023) Módszertani ajánlás A járművezetés bódult állapotban bűncselekmény orvosszakértői véleményezésének egyes kérdéseiről. Belügyi Szemle 71:7, pages 1141-1168.
Crossref
Giorgia Corli, Micaela Tirri, Sabrine Bilel, Arianna Giorgetti, Tatiana Bernardi, Federica Boccuto, Martina Borsari, Raffaele Giorgetti & Matteo Marti. (2023) Ethanol enhances JWH-018-induced impairment of sensorimotor and memory functions in mice: From preclinical evidence to forensic implication in Driving Under the Influence of Drugs. Drug and Alcohol Dependence 247, pages 109888.
Crossref
Armiel Suriaga, Ruth M. Tappen, Elizabeth R. Aston, Lenny Chiang‐Hanisko & David Newman. (2022) Cannabinoids and synthetic cannabinoids as a cause of death: Trends and their healthcare implications. Journal of Nursing Scholarship 55:3, pages 623-636.
Crossref
Beth M. Wiese, Angelica Alvarez Reyes, Todd W. Vanderah & Tally M. Largent-Milnes. (2023) The endocannabinoid system and breathing. Frontiers in Neuroscience 17.
Crossref
Rita Roque-BravoRafaela Sofia SilvaRui F. MalheiroHelena CarmoFélix CarvalhoDiana Dias da Silva & João Pedro Silva. (2023) Synthetic Cannabinoids: A Pharmacological and Toxicological Overview. Annual Review of Pharmacology and Toxicology 63:1, pages 187-209.
Crossref
Gábor Simon, Dénes Tóth, Veronika Heckmann, Mátyás Mayer & Mónika Kuzma. (2022) Simultaneous fatal poisoning of two victims with 4F-MDMB-BINACA and ethanol. Forensic Toxicology 41:1, pages 151-157.
Crossref
Vasco Orazietti, Giuseppe Basile, Raffaele Giorgetti & Arianna Giorgetti. (2022) Effects of synthetic cannabinoids on psychomotor, sensory and cognitive functions relevant for safe driving. Frontiers in Psychiatry 13.
Crossref
Stefano D’Errico, Martina Zanon, Davide Radaelli, Monica Concato, Martina Padovano, Matteo Scopetti, Paola Frati & Vittorio Fineschi. (2022) Acute Kidney Injury (AKI) in Young Synthetic Cannabinoids Abusers. Biomedicines 10:8, pages 1936.
Crossref
Pruntha YoganathanHugh ClaridgeLucy ChesterAmir EnglundNicola J. KalkCaroline S. Copeland. (2022) Synthetic Cannabinoid-Related Deaths in England, 2012–2019. Cannabis and Cannabinoid Research 7:4, pages 516-525.
Crossref
Orion Santangelo, Julie Marie Baldwin & John Stogner. (2022) Does cannabis testing in the military drive synthetic cannabinoid use? Self-reported use motivations among justice-involved veterans. International Journal of Drug Policy 106, pages 103756.
Crossref
Tiana J McMann, Alec Calac, Matthew Nali, Raphael Cuomo, James Maroulis & Tim K Mackey. (2022) Synthetic Cannabinoids in Prisons: Content Analysis of TikToks. JMIR Infodemiology 2:1, pages e37632.
Crossref
Eef L. Theunissen, Johannes T. Reckweg, Nadia R. P. W. Hutten, Kim P. C. Kuypers, Stefan W. Toennes, Merja A. Neukamm, Sebastian Halter & Johannes G. Ramaekers. (2021) Psychotomimetic symptoms after a moderate dose of a synthetic cannabinoid (JWH-018): implications for psychosis. Psychopharmacology 239:5, pages 1251-1261.
Crossref
Jack Markham, Eric Sparkes, Rochelle Boyd, Shuli Chen, Jamie J. Manning, David Finlay, Felcia Lai, Eila McGregor, Callan J. Maloney, Roy R. Gerona, Mark Connor, Iain S. McGregor, David E. Hibbs, Michelle Glass, Richard C. Kevin & Samuel D. Banister. (2022) Defining Steric Requirements at CB 1 and CB 2 Cannabinoid Receptors Using Synthetic Cannabinoid Receptor Agonists 5F-AB-PINACA, 5F-ADB-PINACA, PX-1, PX-2, NNL-1, and Their Analogues . ACS Chemical Neuroscience 13:8, pages 1281-1295.
Crossref
Marcela C. Smid & Mishka Terplan. (2022) What Obstetrician–Gynecologists Should Know About Substance Use Disorders in the Perinatal Period. Obstetrics & Gynecology 139:2, pages 317-337.
Crossref
Nina SkokoM.M., Darija SazdanićB.B., Isidora SamojlikN.N., Bela KolaršŠ.Š., Ana MiljkovićR.R. & Vesna Mijatović-JovinM.M.. (2022) Factors influencing knowledge of synthetic cannabinoids: Study conducted among future healthcare professionals. Hospital Pharmacology - International Multidisciplinary Journal 9:3, pages 1207-1214.
Crossref
Andreas BüttnerAndreas Büttner. 2022. Neuropathologie des Drogenmissbrauchs. Neuropathologie des Drogenmissbrauchs 23 90 .
Claude Cyr, Mellar P. Davis, Danial Schecter & Paul DaeninckMellar P. Davis. 2022. Cannabis and Cannabinoid-Based Medicines in Cancer Care. Cannabis and Cannabinoid-Based Medicines in Cancer Care 91 115 .
Melissa A. Jackson, Amanda L. Brown, Jennifer Johnston, Richard Clancy, Iain McGregor, Raimondo Bruno, Nick Lintzeris, Mark Montebello, Jennifer Luksza, Jenny Bowman, Nghi Phung, Dave Allsop & Adrian J. Dunlop. (2021) The use and effects of synthetic cannabinoid receptor agonists by New South Wales cannabis treatment clients. Journal of Cannabis Research 3:1.
Crossref
Shane Darke, Samuel Banister, Michael Farrell, Johan Duflou & Julia Lappin. (2021) ‘Synthetic cannabis’: A dangerous misnomer. International Journal of Drug Policy 98, pages 103396.
Crossref
Adam Ametovski, Elizabeth A. Cairns, Katharina Elisabeth Grafinger, Annelies Cannaert, Marie H. Deventer, Shuli Chen, Xinyi Wu, Caitlin E. Shepperson, Felcia Lai, Ross Ellison, Roy Gerona, Karen Blakey, Richard Kevin, Iain S. McGregor, David E. Hibbs, Michelle Glass, Christophe Stove, Volker Auwärter & Samuel D. Banister. (2021) NNL-3: A Synthetic Intermediate or a New Class of Hydroxybenzotriazole Esters with Cannabinoid Receptor Activity?. ACS Chemical Neuroscience 12:21, pages 4020-4036.
Crossref
Oyekoya T. Ayonrinde, Oyedeji A. Ayonrinde, Derrick Van Rooyen, Robert Tait, Mikaela Dunn, Shailender Mehta, Scott White & Oyekunle K. Ayonrinde. (2020) Association between gestational cannabis exposure and maternal, perinatal, placental, and childhood outcomes. Journal of Developmental Origins of Health and Disease 12:5, pages 694-703.
Crossref
Philip Wiredu Addo, Vincent Desaulniers Brousseau, Victorio Morello, Sarah MacPherson, Maxime Paris & Mark Lefsrud. (2021) Cannabis chemistry, post-harvest processing methods and secondary metabolite profiling: A review. Industrial Crops and Products 170, pages 113743.
Crossref
Astrid Coronado-Álvarez, Karen Romero-Cordero, Lorena Macías-Triana, Agnes Tatum-Kuri, Alba Vera-Barrón, Henning Budde, Sérgio Machado, Tetsuya Yamamoto, Claudio Imperatori & Eric Murillo-Rodríguez. (2021) The synthetic CB1 cannabinoid receptor selective agonists: Putative medical uses and their legalization. Progress in Neuro-Psychopharmacology and Biological Psychiatry 110, pages 110301.
Crossref
Stefania Chiappini, Alessio Mosca, Andrea Miuli, Maria Chiara Santovito, Laura Orsolini, John Martin Corkery, Amira Guirguis, Mauro Pettorruso, Giovanni Martinotti, Massimo Di Giannantonio & Fabrizio Schifano. (2021) New Psychoactive Substances and Suicidality: A Systematic Review of the Current Literature. Medicina 57:6, pages 580.
Crossref
Eef L. Theunissen, Johannes T. Reckweg, Nadia R.P.W. Hutten, Kim P.C. Kuypers, Stefan W. Toennes, Merja A. Neukamm, Sebastian Halter & Johannes G. Ramaekers. (2021) Intoxication by a synthetic cannabinoid (JWH-018) causes cognitive and psychomotor impairment in recreational cannabis users. Pharmacology Biochemistry and Behavior 202, pages 173118.
Crossref
Marianne Tiemensma, John David Rutherford, Timothy Scott & Steven Karch. (2020) Emergence of Cumyl-PEGACLONE-related fatalities in the Northern Territory of Australia. Forensic Science, Medicine and Pathology 17:1, pages 3-9.
Crossref
Tatsuhiko Murata, Kanako Noritake, Toshihiko Aki & Koichi Uemura. (2021) Possible roles of AMPK and macropinocytosis in the defense responses against Δ9-THC toxicity on HL-1 cardiomyocytes. Toxicology Reports 8, pages 980-987.
Crossref
Andreas BüttnerAndreas Büttner. 2021. Neuropathology of Drug Abuse. Neuropathology of Drug Abuse 23 87 .
Nadja Walle, Frederike Nordmeier, Adrian A. Doerr, Benjamin Peters, Matthias W. Laschke, Michael D. Menger, Peter H. Schmidt, Markus R. Meyer & Nadine Schaefer. (2020) Comparison of in vitro and in vivo models for the elucidation of metabolic patterns of 7‐azaindole‐derived synthetic cannabinoids exemplified using cumyl‐5F‐P7AICA . Drug Testing and Analysis 13:1, pages 74-90.
Crossref
Annelies Cannaert, Eric Sparkes, Edward Pike, Jia Lin Luo, Ada Fang, Richard C. Kevin, Ross Ellison, Roy Gerona, Samuel D. Banister & Christophe P. Stove. (2020) Synthesis and in Vitro Cannabinoid Receptor 1 Activity of Recently Detected Synthetic Cannabinoids 4F-MDMB-BICA, 5F-MPP-PICA, MMB-4en-PICA, CUMYL-CBMICA, ADB-BINACA, APP-BINACA, 4F-MDMB-BINACA, MDMB-4en-PINACA, A-CHMINACA, 5F-AB-P7AICA, 5F-MDMB-P7AICA, and 5F-AP7AICA . ACS Chemical Neuroscience 11:24, pages 4434-4446.
Crossref
Nadine Schaefer, Ann-Katrin Kröll, Christina Körbel, Matthias W. Laschke, Michael D. Menger, Hans H. Maurer, Markus R. Meyer & Peter H. Schmidt. (2020) Time- and temperature-dependent postmortem concentration changes of the (synthetic) cannabinoids JWH-210, RCS-4, as well as ∆9-tetrahydrocannabinol following pulmonary administration to pigs. Archives of Toxicology 94:5, pages 1585-1599.
Crossref
Dino Luethi & Matthias E. Liechti. (2020) Designer drugs: mechanism of action and adverse effects. Archives of Toxicology 94:4, pages 1085-1133.
Crossref
Abu Shafi, Alex J. Berry, Harry Sumnall, David M. Wood & Derek K. Tracy. (2020) New psychoactive substances: a review and updates. Therapeutic Advances in Psychopharmacology 10, pages 204512532096719.
Crossref
Jacquelyn Caterino, Jason Clark & Joshua C. Yohannan. (2019) Analysis of synthetic cannabinoids on paper before and after processing for latent print using DFO and ninhydrin. Forensic Science International 305, pages 110000.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.